Inozyme Pharma Inc (NAS:INZY)
$ 4.07 -0.35 (-7.92%) Market Cap: 273.09 Mil Enterprise Value: 198.76 Mil PE Ratio: 0 PB Ratio: 2.68 GF Score: 41/100

Inozyme Pharma Inc at Bank of America Biotech SMID Cap Conference Transcript

Dec 08, 2022 / 01:00PM GMT
Release Date Price: $1.55 (+6.90%)
Unidentified Participant

Yes, ladies and gentlemen, the program is about to begin. A reminder that you can submit questions at any time via the Ask Questions tab on the webcast page. At this time, it is my pleasure to turn the program over to your host, Tazeen Ahmad.

Tazeen Ahmad
BofA Securities - Analyst

Great. Thank you, [Joe]. Good morning, everybody, and thanks for joining us for our second day of our virtual Bank of America SMID Biotech Conference. It's my pleasure to have my first presenting company of the day, Inozyme. Presenting for Inozyme is CEO Axel Bolte. Good morning. Thank you for joining us today.

Axel Bolte
Inozyme Pharma, Inc. - Co-Founder, President, & CEO

Good morning, Tazeen, and thank you very much for having us on your conference. We're delighted to talk to you about our company.

Questions & Answers

Tazeen Ahmad
BofA Securities - Analyst

For those who may not be familiar, we only have 30 minutes for this con. I want us to get into a lot of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot